Imperative Care Appoints Henrietta Fore and Stacy Enxing Seng to Board of Directors

Imperative Care Appoints Henrietta Fore and Stacy Enxing Seng to Board of Directors




Imperative Care Appoints Henrietta Fore and Stacy Enxing Seng to Board of Directors

Respected leaders bring deep industry expertise and diverse perspectives to further enable company’s substantial growth

CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced the appointment of Henrietta Fore and Stacy Enxing Seng to the company’s Board of Directors, effective immediately.

“The addition of Henrietta and Stacy to Imperative Care’s Board of Directors will prove invaluable as they bring varied backgrounds and areas of expertise both within and outside of the medical device industry,” said Fred Khosravi, CEO and Chairman of Imperative Care. “We have worked very deliberately in our efforts to attract extraordinary people to Imperative Care’s Board, as the right balance of knowledge, experience, and thoughtful governance is absolutely critical to achieving our mission of transforming medical innovation and bringing better care to more patients.”

As an accomplished executive leader, Stacy Enxing Seng has more than 25 years in sales, marketing and operational leadership roles building innovative technology portfolios, demonstrated clinical outcomes, exceptional management teams and world-class company cultures. She brings a strong track record of helping develop and advance life-saving technologies from early concept to valuable solutions in the hands of physicians. She has been recognized as one of Minnesota’s Top 100 Women in Business and currently holds numerous independent director positions at Fogarty Innovation, Sonova Holding AG, LivaNova, PLC, and Corza Medical and serves as Board chair for Contego Medical and Cala Health. Additionally, she has been an Operating Partner at Lightstone Ventures since 2016. Enxing Seng received a Bachelor of Arts in Public Policy from Michigan State University and a Master of Business Administration from Harvard Business School.

“This is an exciting time for Imperative Care. The company is undergoing rapid and meaningful growth with its successful stroke treatment portfolio, while nurturing development programs that look beyond stroke intervention and tackle gaps across the entire stroke patient journey. Together with Truvic, Imperative Care is poised to be a strong leader in the vascular space, and I look forward to working alongside the company’s Board members and executive leadership team to further advance this urgent and patient-focused mission,” said Enxing Seng.

Henrietta Fore joins the company’s Board with more than four decades of public service in a variety of sectors. She recently served as the 7th executive director of United Nations Children’s Fund (UNICEF) and currently holds the position of Board chairman and chief executive officer of Holsman International, a manufacturing and consulting company. Under President George W. Bush, Fore served as the first female Administrator of the United States Agency for International Development (USAID) and Director of U.S. Foreign Assistance, Under Secretary of Management in the Department of State, and Director of the United States Mint. She has held a number of other leadership positions such as an Independent Director for ExxonMobil and General Mills. Fore has also received esteemed honors such as the United States Secretary of State’s Distinguished Service Award in 2009. She has a Bachelor of Arts in History, Economics and Art from Wellesley College and a Master of Science in public administration from the University of Northern Colorado.

“Stroke is a devastating disease impacting more than 15 million people worldwide each year, according to the World Health Organization. Navigating stroke care from detection through recovery is critical to improving patient outcomes. Imperative Care is working to provide a complete solution that increases access to patient care, improves stroke treatment, and helps patients return to their daily activities,” said Fore. “The company is leveraging innovative solutions in stroke care for patients suffering from devastating vascular diseases, and I look forward to helping guide Imperative Care as it progresses in this purposeful mission.”

“We are pleased to have both Stacy and Henrietta join our esteemed board of leaders,” said John Hamre, Ph.D., Chairman of Imperative Care’s Nominating and Governance Committee. “These women are inspirational forces in their respective fields. They bring a wealth of knowledge and experience that will undoubtedly help us meet the highest possible standards on behalf of patients and the clinical community.”

About Imperative Care, Inc.

Imperative Care is a medical technology company focused on developing the next generation of innovative solutions to address the vast and urgent needs in stroke. The company has two 510(k) cleared product platforms, as well as an expansive stroke technology development pipeline. In addition, Imperative Care’s wholly owned subsidiary Truvic is developing solutions for the treatment of peripheral vascular disease. Imperative Care and Truvic are based in Campbell, Calif. Visit https://imperativecare.com to learn more.

Contacts

Investor Contact:
Matt Garrett, CFO

Imperative Care, Inc.

408-476-1672

mgarrett@imperativecare.com

Media Contact:
Lara Lingenbrink

Imperative Care, Inc.

858-525-1414

llingenbrink@imperativecare.com